Your browser doesn't support javascript.
loading
Efficacy of Ramucirumab Versus Sorafenib as Subsequent Treatment for Hepatocellular Carcinoma.
Maesaka, Kazuki; Sakamori, Ryotaro; Yamada, Ryoko; Tahata, Yuki; Ohkawa, Kazuyoshi; Oshita, Masahide; Tamura, Shinji; Hagiwara, Hideki; Mita, Eiji; Yakushijin, Takayuki; Inada, Masami; Kodama, Takahiro; Hikita, Hayato; Tatsumi, Tomohide; Takehara, Tetsuo.
Afiliación
  • Maesaka K; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Sakamori R; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Yamada R; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Tahata Y; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Ohkawa K; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Oshita M; Department of Gastroenterology and Hepatology, Osaka Police Hospital, Osaka, Japan.
  • Tamura S; Department of Gastroenterology and Hepatology, Minoh City Hospital, Minoh, Japan.
  • Hagiwara H; Department of Gastroenterology and Hepatology, Kansai Rosai Hospital, Amagasaki, Japan.
  • Mita E; Department of Gastroenterology and Hepatology, National Hospital Organization Osaka National Hospital, Osaka, Japan.
  • Yakushijin T; Department of Gastroenterology and Hepatology, Osaka General Medical Center, Osaka, Japan.
  • Inada M; Department of Gastroenterology and Hepatology, Toyonaka Municipal Hospital, Toyonaka, Japan.
  • Kodama T; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Hikita H; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Tatsumi T; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Takehara T; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan; takehara@gh.med.osaka-u.ac.jp.
Anticancer Res ; 41(4): 2187-2192, 2021 Apr.
Article en En | MEDLINE | ID: mdl-33813432
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Anticuerpos Monoclonales Humanizados / Sorafenib / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies País/Región como asunto: Asia Idioma: En Revista: Anticancer Res Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Anticuerpos Monoclonales Humanizados / Sorafenib / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies País/Región como asunto: Asia Idioma: En Revista: Anticancer Res Año: 2021 Tipo del documento: Article